Publications of Florian Holsboer
All genres
Journal Article (878)
61.
Journal Article
: Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic Properties. The Journal of neuroscience: the official journal of the Society for Neuroscience 35 (24), pp. 9007 - 16 (2015)
62.
Journal Article
76 (6), pp. e802 - e808 (2015)
Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies. The Journal of clinical psychiatry 63.
Journal Article
: CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study. PHARMACOGENOMICS 16 (7), pp. 689 - 701 (2015)
64.
Journal Article
51, pp. 444 - 458 (2015)
Searching for non-genetic molecular and imaging PTSD risk and resilience markers: Systematic review of literature and design of the German Armed Forces PTSD biomarker study. PSYCHONEUROENDOCRINOLOGY 65.
Journal Article
103, pp. 267 - 275 (2014)
Increased HPA axis response to psychosocial stress in remitted depression: the influence of coping style. BIOLOGICAL PSYCHOLOGY 66.
Journal Article
: Loratadine and Analogues: Discovery and Preliminary Structure-Activity Relationship of Inhibitors of the Amino Acid Transporter B(0)AT2. JOURNAL OF MEDICINAL CHEMISTRY 57 (22), pp. 9473 - 9479 (2014)
67.
Journal Article
: Association of FKBP51 with Priming of Autophagy Pathways and Mediation of Antidepressant Treatment Response: Evidence in Cells, Mice, and Humans. PLOS MEDICINE 11 (11), e1001755 (2014)
68.
Journal Article
49, pp. 229 - 243 (2014)
Mice selected for extremes in stress reactivity reveal key endophenotypes of major depression: A translational approach. PSYCHONEUROENDOCRINOLOGY 69.
Journal Article
76 (7), pp. E15 - E17 (2014)
Blood Mononuclear Cell Proteome Suggests Integrin and Ras Signaling as Critical Pathways for Antidepressant Treatment Response. BIOLOGICAL PSYCHIATRY 70.
Journal Article
: Three-Year long-term outcome of 458 naturalistically treated inpatients with major depressive episode: severe relapse rates and risk factors. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE 264 (7), pp. 567 - 575 (2014)
71.
Journal Article
45, pp. 87 - 95 (2014)
Hypothalamo-pituitary-adrenal axis activity evolves differentially in untreated versus treated multiple sclerosis. PSYCHONEUROENDOCRINOLOGY 72.
Journal Article
: A Polymorphism in the Crhr1 Gene Determines Stress Vulnerability in Male Mice. ENDOCRINOLOGY 155 (7), pp. 2500 - 2510 (2014)
73.
Journal Article
44, pp. 35 - 46 (2014)
Dexamethasone stimulated gene expression in peripheral blood indicates glucocorticoid-receptor hypersensitivity in job-related exhaustion. PSYCHONEUROENDOCRINOLOGY 74.
Journal Article
24 (6), pp. 907 - 918 (2014)
Evidence supporting the match/mismatch hypothesis of psychiatric disorders. EUROPEAN NEUROPSYCHOPHARMACOLOGY 75.
Journal Article
19 (5), pp. 539 - 561 (2014)
Are there meaningful biomarkers of treatment response for depression? DRUG DISCOVERY TODAY 76.
Journal Article
: Deficiency of FK506-binding protein ( FKBP) 51 alters sleep architecture and recovery sleep responses to stress in mice. JOURNAL OF SLEEP RESEARCH 23 (2), pp. 176 - 185 (2014)
77.
Journal Article
19 (2), pp. 165 - 175 (2014)
The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study. CNS SPECTRUMS 78.
Journal Article
141 (3), pp. 300 - 334 (2014)
Neuroscience-driven discovery and development of sleep therapeutics. PHARMACOLOGY & THERAPEUTICS 79.
Journal Article
4, e359 (2014)
Bidirectional rescue of extreme genetic predispositions to anxiety: impact of CRH receptor 1 as epigenetic plasticity gene in the amygdala. TRANSLATIONAL PSYCHIATRY 80.
Journal Article
16 (1), pp. 5 - 7 (2014)
Redesigning antidepressant drug discovery. [Guest Editorial]. Dialogues in clinical neuroscience